Profil
Robert H.
Cutler is Senior Vice President & Head-Legal Affairs at Senti Biosciences, Inc. since 2024.
Formerly, Mr. Cutler was Chief Legal Officer at Telesis Bio, Inc. from 2021 to 2024, General Counsel at Viridos, Inc. from 2016 to 2021, Secretary & General Counsel at LifeVantage Corp.
from 2012 to 2015, Vice President-Business Development at Somaxon Pharmaceuticals, Inc., and Corporate Officer at Brobeck, Phleger & Harrison LLP from 1999 to 2001.
Education includes undergraduate studies at the University of Utah and graduate studies at Brigham Young University.
Aktive Positionen von Robert Cutler
| Unternehmen | Position | Beginn |
|---|---|---|
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | General Counsel | 01.11.2024 |
Ehemalige bekannte Positionen von Robert Cutler
| Unternehmen | Position | Ende |
|---|---|---|
| TELESIS BIO, INC. | General Counsel | 31.10.2024 |
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes genomic-driven solutions and products | General Counsel | 01.01.2021 |
| LIFEVANTAGE CORPORATION | Investor Relations Kontakt | 08.05.2015 |
Brobeck, Phleger & Harrison LLP
Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.07.2001 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Robert Cutler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
LifeVantage Corp.
LifeVantage Corp. Pharmaceuticals: OtherHealth Technology Develops, manufactures and distributes nutraceutical dietary supplement | Health Technology |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes genomic-driven solutions and products | Commercial Services |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brobeck, Phleger & Harrison LLP
Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Telesis Bio, Inc.
Telesis Bio, Inc. Medical SpecialtiesHealth Technology Engages in R&D, manufacturing and sale of synthetic biology instruments | Health Technology |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
















